Patient
P2B-072
completed Phase IIA Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · State Health Centre Oncology Department (Budapest, Hungary) (Dr. Clarke)
consented 2013-01-28
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
Grade 1 nausea with onset in cycle 6 (2013-05-30); assessed as not related to study drug (not related); resolved 2013-06-02.
Grade 2 ejection fraction decreased with onset in cycle 2 (2013-03-26); assessed as related to study drug (probable); resolved 2013-06-04.
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.